SCHEMBL6741171

SCHEMBL6741171

c1cncc(-c2coc3cc(-c4ccsc4)ccc23)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 6/20 0.56
CYP3A4 P08684 2/20 0.56
CYP2C9 P11712 2/20 0.56
CYP2B6 P20813 2/20 0.56
CYP2C19 P33261 2/20 0.56
PPARA Q07869 1/20 0.45
HDAC1 Q13547 1/20 0.42
CYP19A1 P11511 2/20 0.40
CYP11B1 P15538 2/20 0.40
CYP11B2 P19099 1/20 0.40
CYP2E1 P05181 1/20 0.40
CYP2D6 P10635 1/20 0.40
FYN P06241 1/20 0.38
CHEK2 O96017 1/20 0.38
KDR P35968 1/20 0.38
PIK3CA P42336 1/20 0.37
ACVR1 Q04771 1/20 0.37
AAK1 Q2M2I8 1/20 0.37
PIN1 Q13526 1/20 0.36
KCNA3 P22001 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6739723 0.99 CYP2A6 (0.55) CYP2A6CYP3A4CYP2C9CYP2B6CYP2C19
SCHEMBL6741783 0.87 CYP19A1 (0.49) CYP2A6CYP3A4CYP19A1CYP11B1CYP11B2
SCHEMBL6740241 0.84 ACVR1 (0.48) CYP2A6CYP3A4CYP19A1CYP11B1CYP11B2
SCHEMBL6736802 0.82 CYP19A1 (0.49) CYP3A4CYP2C9CYP2B6CYP2C19PPARA
SCHEMBL6740187 0.81 TDO2 (0.48) CYP3A4PPARAHDAC1CYP19A1CYP11B1
SCHEMBL6741025 0.81 MIF (0.48) CYP3A4CYP2C9CYP2B6CYP2C19CYP19A1
SCHEMBL6740852 0.81 CYP3A4 (0.54) CYP3A4CYP2C9CYP2B6CYP2C19PPARA
SCHEMBL6741695 0.80 TDO2 (0.47) CYP3A4CYP2C9CYP2B6CYP2C19PPARA
Bromide SCHEMBL6741296 0.80 MIF (0.47) CYP3A4CYP2C9CYP2B6CYP2C19CYP19A1
SCHEMBL6736043 0.80 AXL (0.59) CYP3A4CYP2C9CYP2B6CYP2C19CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689798-B2 STEROID ALPHA-HYDROXYLASE AND STEROID LYASE INHIBITORS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-02-10 US claimed
US-6689798-B2 STEROID ALPHA-HYDROXYLASE AND STEROID LYASE INHIBITORS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-02-10 US disclosed
US-20030149079-A1 Novel benzofuran derivatives DAIICHI PHARMACEUTICAL CO., LTD. 2003-08-07 US disclosed
EP-1283208-A1 NOVEL BENZOFURAN DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-02-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030149079-A1 Novel benzofuran derivatives CYP17A1, CYP21A2, HSD17B7 CYP2A6 92/4885CYP3A4 82/4885CYP2C9 103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.